JPWO2020070088A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020070088A5
JPWO2020070088A5 JP2021518664A JP2021518664A JPWO2020070088A5 JP WO2020070088 A5 JPWO2020070088 A5 JP WO2020070088A5 JP 2021518664 A JP2021518664 A JP 2021518664A JP 2021518664 A JP2021518664 A JP 2021518664A JP WO2020070088 A5 JPWO2020070088 A5 JP WO2020070088A5
Authority
JP
Japan
Prior art keywords
oxo
chloro
chromen
phenoxy
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504298A (ja
JP2022504298A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/076502 external-priority patent/WO2020070088A1/en
Publication of JP2022504298A publication Critical patent/JP2022504298A/ja
Publication of JP2022504298A5 publication Critical patent/JP2022504298A5/ja
Publication of JPWO2020070088A5 publication Critical patent/JPWO2020070088A5/ja
Ceased legal-status Critical Current

Links

JP2021518664A 2018-10-03 2019-10-01 B型肝炎ウイルス疾患の処置および予防のためのフラボン誘導体 Ceased JP2022504298A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/109241 2018-10-03
CN2018109241 2018-10-03
PCT/EP2019/076502 WO2020070088A1 (en) 2018-10-03 2019-10-01 Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease

Publications (3)

Publication Number Publication Date
JP2022504298A JP2022504298A (ja) 2022-01-13
JP2022504298A5 JP2022504298A5 (https=) 2024-03-04
JPWO2020070088A5 true JPWO2020070088A5 (https=) 2024-03-04

Family

ID=68172177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518664A Ceased JP2022504298A (ja) 2018-10-03 2019-10-01 B型肝炎ウイルス疾患の処置および予防のためのフラボン誘導体

Country Status (5)

Country Link
US (1) US11708344B2 (https=)
EP (1) EP3860984A1 (https=)
JP (1) JP2022504298A (https=)
CN (1) CN112912371A (https=)
WO (1) WO2020070088A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020052774A1 (en) * 2018-09-14 2020-03-19 F. Hoffmann-La Roche Ag Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease
WO2020120528A1 (en) * 2018-12-14 2020-06-18 F. Hoffmann-La Roche Ag N-containing chromen-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infection
JP2022514470A (ja) * 2018-12-14 2022-02-14 エフ.ホフマン-ラ ロシュ アーゲー B型肝炎ウイルス感染症を治療および予防するためのクロマン-4-オン誘導体
CN116947799B (zh) * 2023-03-08 2024-05-03 上海泽德曼医药科技有限公司 酚类化合物、其制备方法及其在医药上的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1223928A2 (en) * 1999-07-08 2002-07-24 Patrick Thomas Prendergast Use of flavones, coumarins and related compounds to treat infections
GB0216371D0 (en) 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
CN100415731C (zh) 2004-12-30 2008-09-03 财团法人工业技术研究院 治疗b型肝炎的化合物及其医药组合物
CA2652617A1 (en) 2006-05-19 2007-11-29 The Hong Kong Polytechnic University Flavonoid dimers and methods of making and using such
WO2013127361A1 (en) 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers
WO2014074976A1 (en) 2012-11-09 2014-05-15 Musc Foundation For Research Development Compositions and methods for treating neurological diseases or injury
CN109394752A (zh) 2013-10-21 2019-03-01 德雷克塞尔大学 治疗慢性乙型肝炎病毒感染的sting激动剂的用途
WO2015161309A1 (en) 2014-04-19 2015-10-22 Jia Zhou Apigenin analogs, compositions, and methods related thereto
US20210387996A1 (en) 2018-10-24 2021-12-16 Hoffmann-La Roche Inc. Tricyclic compounds for the treatment and prophylaxis of hepatitis b virus disease

Similar Documents

Publication Publication Date Title
RU2506257C2 (ru) Замещенные пирролидин-2-карбоксамиды
CN101175724B (zh) 吡咯烷衍生物或其盐
JP2013517283A5 (https=)
JP2008515962A5 (https=)
RU2383524C2 (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2010508338A5 (https=)
CN1178922C (zh) 取代的1-氨基烷基内酰胺化合物及其作为毒蕈碱受体拮抗剂的用途
CN1426405A (zh) 新型环状酰胺衍生物
RU2009102770A (ru) Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
JP2008509982A5 (https=)
JP2007502265A5 (https=)
JP2006525299A5 (https=)
CN1473040A (zh) Cb1受体拮抗剂与西布茶明的组合形式、其药物组合物及其在治疗肥胖病中的应用
AR058754A1 (es) Procesos para preparar compuestos intermediarios utiles para la preparacion de ezetimibe
JP2007508346A5 (https=)
CN1717389A (zh) 作为ppar活化剂的苯基取代的哌啶化合物
JP2008516922A5 (https=)
JPWO2020070088A5 (https=)
JP2017525697A5 (https=)
JP2009256208A (ja) フタリド誘導体またはその薬学的に許容される塩
CN1030915C (zh) 苯并咪唑衍生物的制备方法
JP5850972B2 (ja) Pde4インヒビターとしてのピラゾロン誘導体
CN1795191A (zh) 4-取代喹啉衍生物、制备方法和中间体以及含有其的药物组合物
JP2020500192A5 (https=)
RU2012127272A (ru) Производные пирролидина